ARDX
Ardelyx Inc.
Company Overview
| Mkt Cap | $1.23B | Price | $6.06 |
| Volume | 18.73M | Change | +20.96% |
| P/E Ratio | -31.5 | Open | $6.43 |
| Revenue | $333.6M | Prev Close | $5.01 |
| Net Income | $-39.1M | 52W Range | $3.21 - $6.78 |
| Div Yield | N/A | Target | $11.36 |
| Overall | 45 | Value | 40 |
| Quality | -- | Technical | 50 |
No chart data available
Stock Overview
Updated DailyArdelyx Inc. (ARDX) is a leading Healthcare company in the Biotechnology industry, currently trading at $6.06 with a market capitalization of $1.23 billion. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ARDX with a volume of 18.73 million shares. The stock opened up 28.34% from yesterday's close of $5.01. Current analyst estimates project earnings of $-0.34 per share for this year, with next year targeting $0.01.
ARDX demonstrates neutral technical outlook based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OPK, AMGN, SNY, ABT, AZN.
Key investment considerations for ARDX include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 87.5%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 03:53 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ARDX | $6.06 | +21.0% | 18.73M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |